From Casetext: Smarter Legal Research

Vaccine Ctr. LLC v. GlaxoSmithKline LLC

UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Feb 20, 2013
Case No. 2:12-cv-01849-JCM-NJK (D. Nev. Feb. 20, 2013)

Opinion

Case No. 2:12-cv-01849-JCM-NJK

02-20-2013

THE VACCINE CENTER LLC, d/b/a THE VACCINE CENTER AND TRAVEL MEDICAL CLINIC Plaintiff, v. GLAXOSMITHKLINE LLC, et al., Defendants.


ORDER GRANTING IN PART

MOTION FOR EMERGENCY

HEARING (Docket No. 41)

Before the Court is Plaintiff's countermotion for emergency hearing, Docket No. 41, seeking a hearing and an order that Defendant Apexus, Inc. ("Defendant") produce Exhibits A and B submitted in support of its motion to dismiss. Defendant filed a responsive brief, see Reply I.S.O. Mot. To Seal (Docket No. 47), and Plaintiff filed a reply (Docket No. 48). The Court finds that a hearing on the motion is unnecessary, see Local Rule 78-2, so that aspect of the pending motion is DENIED. But the motion is hereby GRANTED in part as provided below.

Plaintiff's motion is based primarily on its contention that it cannot properly respond to Defendant's motion to dismiss without reviewing Exhibits A and B. See Mot. at 4; Coulthard Aff. at ¶ 4. Defendant asserts that it has agreed to produce to Plaintiff those exhibits in unredacted form, but only if designated as "attorneys' eyes only" pursuant to a protective order. See Reply I.S.O. Mot. To Seal at 2.

The Court hereby ORDERS the parties to meet and confer, no later than February 21, 2013, regarding a protective order that can be entered in this case. The Court further ORDERS that the parties shall file a proposed protective order for the Court's review no later than February 22, 2013. Once a protective order is entered, Defendant shall have three days to designate Exhibits A and B as it sees fit and to produce unredacted versions to Plaintiff. To the extent Plaintiff wishes to dispute Defendant's designations for Exhibits A and B, it may do so through the normal processes that will be included in the protective order. In the meantime, however, Plaintiff's attorneys will have access to the exhibits so that a response to the motion to dismiss can be submitted expeditiously.

The Court notes that protective orders are fairly routine and almost never require Court intervention. The Court stresses that the parties must make every effort to resolve any differences regarding the protective order amongst themselves. To the extent the dispute between the parties concerns the designation Defendant will choose for Exhibits A and B, that should be resolved after the entry of a protective order and is not grounds for failing to enter the protective order.

To the extent Plaintiff believes it requires an extension for its response to the motion to dismiss, see, e.g., Mot. at 5, that is an issue properly addressed to District Judge Mahan through a separate motion or stipulation.
--------

IT IS SO ORDERED.

_______________

NANCY J. KOPPE

United States Magistrate Judge


Summaries of

Vaccine Ctr. LLC v. GlaxoSmithKline LLC

UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Feb 20, 2013
Case No. 2:12-cv-01849-JCM-NJK (D. Nev. Feb. 20, 2013)
Case details for

Vaccine Ctr. LLC v. GlaxoSmithKline LLC

Case Details

Full title:THE VACCINE CENTER LLC, d/b/a THE VACCINE CENTER AND TRAVEL MEDICAL CLINIC…

Court:UNITED STATES DISTRICT COURT DISTRICT OF NEVADA

Date published: Feb 20, 2013

Citations

Case No. 2:12-cv-01849-JCM-NJK (D. Nev. Feb. 20, 2013)